FFR Technologies

This channel includes news and new technology innovations for fractional flow reserve (FFR) wires, catheters and systems used to measure blood flow across a coronary lesion to determine if a stent is needed or if the plaque stenosis can be treated medically. The section includes iFR, instantaneous wave-free ratio, systems used in the cath lab and noninvasive FFR technologies including computed tomography-FFR. This is also referred to as CT-FFR or FFR-CT.

An example of HeartFlow's FFR-CT analysis of blockage severity in a patient's coronary vessels based on a cardiac CT scan.

News | FFR Technologies

HeartFlow Becomes Publicly Traded Company in Merger With Longview Acquisition Corp.

July 15, 2021 — HeartFlow, which has commercialized noninvasive computed tomography derived fractional flow reserve (FFR ...

July 15, 2021

The Philips Healthcare SyncVision system co-registers iFR hemodynamic blood flow measurements to live angiograms to enable easier assessment of which lesions in a vessel need to be stented and which can be left alone and treated medically.

News | FFR Technologies

First Patient Enrolled in DEFINE GPS Study to Assess PCI Guided by Co-registered iFR Versus Angiography

June 22, 2021 – Philips Healthcare announced the official start of the DEFINE GPS study, with the first patient being ...

June 22, 2021

Some of the top technology news from ACC 2021. Top left, the LAAOS III trial showed benefit when surgeons seal off the LAA during other open heart procedures. Bottom left, the ReCor Paradise renal denervation system helped lower blood pressure in patients who did not respond to medication. Top right, for patients with both heart failure and AFib it makes no differences is therapy is focused on controlling the heart rhythm or heart rate. Bottom right, the FLOWER-MI trial found no benefit to FFR-guided PCI.

Feature | ACC | By Dave Fornell, Editor

Key Cardiology Technology Takeaways at ACC 2021

Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021 Americ ...

June 08, 2021

Sponsored Content

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the wealth of technological advancements, bringing the necessary tools together in a streamlined workflow has remained a challenge for clinicians

Case Study | Baylor Scott and White Heart Hospital

Contemporary PCI: Utilizing State-of-the-Art Technology to Achieve the Best Outcomes

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...

May 05, 2023

The FLOWER-MI trial presented at ACC 2021 found no benefit to FFR-guided PCI in STEMI with multi-vessel disease. #ACC21 #ACC2021 #FFR

News | FFR Technologies

No Benefit to FFR-guided PCI in STEMI Patients With Multi-Vessel Disease

May 17, 2021 — In patients who received a coronary stent for an ST-elevation myocardial infarction (STEMI) heart attack ...

May 17, 2021

The digital technology is reducing reliance on unnecessary invasive diagnostic procedures and is cutting hospital waiting times

News | Artificial Intelligence

NICE Renews Support for Use of AI-powered HeartFlow Analysis

May 12, 2021 — HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced that the National ...

May 12, 2021

Videos | FFR Technologies

VIDEO: Example of the Medis QFR Angiography Image Derived FFR System

This is an example of the Medis Medical Imaging Quantitative Flow Ratio (QFR) system that offers a fractional flow ...

December 16, 2020

The Medis Quantitative Flow Ratio (QFR) is a novel, non-invasive, angiography-based physiologic FFR-like assessment of the presence and extent of coronary artery disease.

News | FFR Technologies

Acist Medical Partners With Medis to Distribute Angiography Image Derived FFR Quantification System

December 16, 2020 – Acist Medical Systems Inc. announced a formal distribution partnership with Medis Medical Imaging to ...

December 16, 2020

Angiography with a co-registered view of pressure drops according iFR readings in a coronary vessel. The DEFINE PCI study showed patients had improved outcomes and less recurrent chest pain at one year using iFR physiologic measurements combined with landmarks shown on angiographic imaging to better guide therapy. Image by Philips Healthcare. #TCT #TCT2020 #TCTconnect

Feature | FFR Technologies | Dave Fornell, Editor

FFR Studies Find Several Surprises at TCT 2020

Fractional flow reserve (FFR) is considered the gold standard measure whether a coronary lesions needs a percutaneous ...

October 30, 2020

Fractional Flow reserve (FFR) selection on the Abbott, St. Jude FFR system console. The TARGET FFR study at #TCT2020 #TCTconnect.

News | FFR Technologies

FFR-guided PCI Optimization Strategy May Lead to Improved Outcomes

October 23, 2020 – Results from the randomized controlled TARGET FFR trial show that while a physiology-guided ...

October 23, 2020

An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone actually was not flow limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings. #TCT2020 #TCTconnect

News | FFR Technologies | Dave Fornell, Editor

FFR-CT Did Not Significantly Reduce Costs But Reduced Rates of Invasive Coronary Angiography

October 22, 2020 – In the FORECAST randomized clinical trial, the use of fractional flow reserve (FFR) derived from ...

October 22, 2020

A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020

News | Cath Lab

Combined FFR and OCT Imaging Can Improve Accuracy of High-Risk Lesion Identification in Patients With Diabetes

October 18, 2020 – Data from the COMBINE (OCT-FFR) study found that the use of FFR combined with OCT imaging can help ...

October 18, 2020

Philip's co-registration technology showing angiography overlaid with iFR in a coronary vessel segment with a system of dots that show regions where the hemodynamic pressure drops occur. This can aid in identifying culprit lesions. #TCT #TCT2020 #TCTconnect

News | FFR Technologies

DEFINE PCI Study One-year Data Show Potential of Treating Residual Ischemia to Improve Outcomes for Coronary Stenting

October 15, 2020 — The one-year results of the late-breaking DEFINE PCI study showed patients had improved outcomes and ...

October 15, 2020

Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), explains the concpet of the Door-to-Unloading (DTU) Trial he is heading, one of several innovations at Tufts Medical Center in Boston. Kapur is also director, Acute Mechanical Circulatory Support Program; director, interventional research laboratories; director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI), Tufts Medical Center. Photo by Dave Fornell

Feature | Tufts Medical Center | Dave Fornell, Editor

Cardiovascular Innovation at Tufts Medical Center

The cardiology program at Tufts Medical Center in Boston is internationally recognized for being on the forefront of ...

August 21, 2020

$The Philips Healthcare OmniWire is the world’s first solid core fractional flow reserve (FFR) pressure wire for coronary artery interventional procedures.$